Now, a new study published in Current Neuropharmacology has sounded the alarm on potential mental health risks associated with GLP-1 agonists. The research shows how these drugs may interact with genes involved in mood regulation and dopamine signalling, including DRD3, BDNF, and CREB1—genes linked to depression, anxiety, and suicidal ideation.
No comments :
Post a Comment
ANONYMOUS COMMENTS WILL NOT BE POSTED!
please use either your real name or a pseudonym.